Literature DB >> 18161030

Variable phenotypes associated with mutations in DOK7.

Jennifer A Anderson1, Jarae J Ng, Constance Bowe, Craig McDonald, David P Richman, Robert L Wollmann, Ricardo A Maselli.   

Abstract

Many patients with the limb-girdle variant of congenital myasthenic syndrome (CMS) possess mutations in the human Dok-7 gene (DOK7). We identified six unrelated CMS patients with DOK7 mutations. Two patients, one mildly and the other moderately affected, were homozygous for the previously described 1263insC mutation. The common 1124_1127dupTGCC mutation was detected in the other four patients, whose clinical phenotypes range from mildly to severely affected. This striking phenotypic heterogeneity found both within and between mutational classes is made more compelling by data from our electrophysiological studies and electron microscopy of the neuromuscular junction (NMJ). Indeed, several aspects of the physiological and morphometric data do not correlate with genotype or severity of clinical phenotype. Overall, our study corroborates the findings of others and provides an additional demonstration of the considerable phenotypic variability associated with CMS due to DOK7 mutations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18161030     DOI: 10.1002/mus.20944

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  12 in total

1.  Ephedrine treatment in congenital myasthenic syndrome due to mutations in DOK7.

Authors:  D Lashley; J Palace; S Jayawant; S Robb; D Beeson
Journal:  Neurology       Date:  2010-05-11       Impact factor: 9.910

2.  LG2 agrin mutation causing severe congenital myasthenic syndrome mimics functional characteristics of non-neural (z-) agrin.

Authors:  Ricardo A Maselli; Jose M Fernandez; Juan Arredondo; Carmen Navarro; Maian Ngo; David Beeson; Orla Cagney; D Colette Williams; Robert L Wollmann; Vladimir Yarov-Yarovoy; Michael J Ferns
Journal:  Hum Genet       Date:  2011-12-29       Impact factor: 4.132

Review 3.  Current status of the congenital myasthenic syndromes.

Authors:  Andrew G Engel
Journal:  Neuromuscul Disord       Date:  2011-11-21       Impact factor: 4.296

Review 4.  Congenital myasthenic syndromes: pathogenesis, diagnosis, and treatment.

Authors:  Andrew G Engel; Xin-Ming Shen; Duygu Selcen; Steven M Sine
Journal:  Lancet Neurol       Date:  2015-04       Impact factor: 44.182

Review 5.  Ephedrine for myasthenia gravis, neonatal myasthenia and the congenital myasthenic syndromes.

Authors:  Charlotte Vrinten; Angeli M van der Zwaag; Stephanie S Weinreich; Rob J P M Scholten; Jan J G M Verschuuren
Journal:  Cochrane Database Syst Rev       Date:  2014-12-17

6.  Phenotype genotype analysis in 15 patients presenting a congenital myasthenic syndrome due to mutations in DOK7.

Authors:  A Ben Ammar; F Petit; N Alexandri; K Gaudon; S Bauché; A Rouche; D Gras; E Fournier; J Koenig; T Stojkovic; A Lacour; P Petiot; F Zagnoli; L Viollet; N Pellegrini; D Orlikowski; L Lazaro; X Ferrer; G Stoltenburg; M Paturneau-Jouas; F Hentati; M Fardeau; D Sternberg; D Hantaï; P Richard; B Eymard
Journal:  J Neurol       Date:  2009-12-11       Impact factor: 4.849

7.  Mutations in MUSK causing congenital myasthenic syndrome impair MuSK-Dok-7 interaction.

Authors:  Ricardo A Maselli; Juan Arredondo; Orla Cagney; Jarae J Ng; Jennifer A Anderson; Colette Williams; Bae J Gerke; Betty Soliven; Robert L Wollmann
Journal:  Hum Mol Genet       Date:  2010-04-06       Impact factor: 6.150

8.  Examination of transcript amounts and activity of protein kinase CK2 in muscle lysates of different types of human muscle pathologies.

Authors:  Dieter Heuss; Janine Klascinski; Steffen W Schubert; Tehmur Moriabadi; Hanns Lochmüller; Said Hashemolhosseini
Journal:  Mol Cell Biochem       Date:  2008-06-14       Impact factor: 3.396

9.  Congenital myasthenic syndrome with tubular aggregates caused by GFPT1 mutations.

Authors:  Velina Guergueltcheva; Juliane S Müller; Marina Dusl; Jan Senderek; Anders Oldfors; Christopher Lindbergh; Susan Maxwell; Jaume Colomer; Cecilia Jimenez Mallebrera; Andres Nascimento; Juan J Vilchez; Nuria Muelas; Janbernd Kirschner; Shahriar Nafissi; Ariana Kariminejad; Yalda Nilipour; Bita Bozorgmehr; Hossein Najmabadi; Carmelo Rodolico; Jörn P Sieb; Beate Schlotter; Benedikt Schoser; Ralf Herrmann; Thomas Voit; Ortrud K Steinlein; Abdolhamid Najafi; Andoni Urtizberea; Doriette M Soler; Francesco Muntoni; Michael G Hanna; Amina Chaouch; Volker Straub; Kate Bushby; Jacqueline Palace; David Beeson; Angela Abicht; Hanns Lochmüller
Journal:  J Neurol       Date:  2011-10-06       Impact factor: 4.849

10.  Mutations in LAMB2 causing a severe form of synaptic congenital myasthenic syndrome.

Authors:  R A Maselli; J J Ng; J A Anderson; O Cagney; J Arredondo; C Williams; H B Wessel; H Abdel-Hamid; R L Wollmann
Journal:  J Med Genet       Date:  2009-03       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.